Historical record - last NADAC publication: 9/22/2021
Product Information
MORPHINE SULFATE ER 50 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $1.5770 per EA under NDC 00115127901. Its NADAC has been published 232 times since Feb 8, 2017.
Strength
50 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115127901
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
9/22/2021
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA200411On Market Since
4/12/2016
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 50 MG CAP has been published 232 times since Feb 8, 2017, and over the history we have for it it has declined 75.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5770 per EA |
|---|---|
| All-time high | $6.5678 (Oct 10, 2018) |
| All-time low | $1.5770 (Sep 22, 2021) |
| Median price | $5.1971 |
| Average price | $4.5779 |
| Largest weekly change | -54.1% (Sep 22, 2021) |
| Weeks tracked | 232 |
| Tracking since | Feb 8, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the MORPHINE SULFATE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 50 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $1.5770 per EA (NDC 00115127901), effective Mar 16, 2022.
How has the price of MORPHINE SULFATE ER 50 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 50 MG CAP has declined 75.8%. It has been tracked across 232 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 50 MG CAP?
Since Feb 8, 2017, the NADAC for MORPHINE SULFATE ER 50 MG CAP has ranged from a low of $1.5770 (Sep 22, 2021) to a high of $6.5678 (Oct 10, 2018), with a median of $5.1971 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 50 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MORPHINE SULFATE ER 50 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures MORPHINE SULFATE ER 50 MG CAP?
MORPHINE SULFATE ER 50 MG CAP (NDC 00115127901) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification